Community-acquired Clostridium difficile-associated Diarrhea, Montréal, 2005-2006: Frequency estimates and their validity

Infection Control and Hospital Epidemiology

Volumn 32, Issue 10, 2011, Pages 1032-1034

  Allard, Robert ^a,b   Dascal, André ^a,b   Camara, Bakary ^a   Létourneau, Josiane ^a,c   Valiquette, Louise ^a,c  

^a Montreal Health and Social Services Agency   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DISEASE ASSOCIATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY;

CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HOSPITALS; HUMANS; QUEBEC; RETROSPECTIVE STUDIES; SENTINEL SURVEILLANCE;

EID: 80053151938     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/661911     Document Type: Article

References (11)

1. Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23(3):529-548.
2. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140-145.
3. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008;179(8):767-772.
4. Kutty PK, Benoit SR, Woods CW, et al. Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005. Infect Control Hosp Epidemiol 2008;29(3): 197-202.
5. Lin MY, Hota B, Khan YM, et al. Quality of traditional surveillance for public reporting of nosocomial bloodstream infection rates. JAMA 2010;304(18):2035-2041.
6. McBryde ES, Brett J, Russo PL, Worth LJ, Bull AL, Richards MJ. Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia. Infect Control Hosp Epidemiol 2009;30(11):1045-1049.
7. Berrington A, Borriello SP, Brazier J, et al. National Clostridium difficile Standards Group: report to the Department of Health. J Hosp Infect 2004;56(1):1-38.
8. title typecontributorPanel 2: surveillance for disease and sources of infection/title. In: Emerging Clostridial Disease Workshop, May 11, 2006, Atlanta, Georgia: summary of proceedings. 2006:25-32. http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM183030.pdf.
9. Kuijper EJ, Coignard B, Tüll P. Emergence of Clostridium difficile- associated disease in North America and Europe. Clin Microbiol Infect 2006;12(suppl 6):2-18.
10. Rabatsky-Ehr T, Purviance K, Mlynarski D, Mshar P, Hadler J, Sosa L. Surveillance for community-associated Clostridium difficile: Connecticut, 2006. MMWR Morb Mortal Wkly Rep 2008; 57(13):340-343.
11. Doherty JA. Final report and recommendations from the National Notifiable Diseases Working Group. Can Commun Dis Rep 2006;32(19):211-225.